1. Home
  2. PTGX vs TNL Comparison

PTGX vs TNL Comparison

Compare PTGX & TNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • TNL
  • Stock Information
  • Founded
  • PTGX 2006
  • TNL 1990
  • Country
  • PTGX United States
  • TNL United States
  • Employees
  • PTGX N/A
  • TNL N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • TNL Hotels/Resorts
  • Sector
  • PTGX Health Care
  • TNL Consumer Discretionary
  • Exchange
  • PTGX Nasdaq
  • TNL Nasdaq
  • Market Cap
  • PTGX 3.3B
  • TNL 3.3B
  • IPO Year
  • PTGX 2016
  • TNL N/A
  • Fundamental
  • Price
  • PTGX $51.07
  • TNL $58.91
  • Analyst Decision
  • PTGX Strong Buy
  • TNL Buy
  • Analyst Count
  • PTGX 8
  • TNL 10
  • Target Price
  • PTGX $70.13
  • TNL $62.30
  • AVG Volume (30 Days)
  • PTGX 608.4K
  • TNL 789.0K
  • Earning Date
  • PTGX 08-06-2025
  • TNL 07-23-2025
  • Dividend Yield
  • PTGX N/A
  • TNL 3.79%
  • EPS Growth
  • PTGX N/A
  • TNL N/A
  • EPS
  • PTGX 0.80
  • TNL 5.78
  • Revenue
  • PTGX $209,180,000.00
  • TNL $3,915,000,000.00
  • Revenue This Year
  • PTGX N/A
  • TNL $4.19
  • Revenue Next Year
  • PTGX $53.09
  • TNL $3.87
  • P/E Ratio
  • PTGX $63.42
  • TNL $10.23
  • Revenue Growth
  • PTGX N/A
  • TNL 2.46
  • 52 Week Low
  • PTGX $33.31
  • TNL $37.77
  • 52 Week High
  • PTGX $60.60
  • TNL $63.31
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 37.60
  • TNL 54.63
  • Support Level
  • PTGX $52.03
  • TNL $58.17
  • Resistance Level
  • PTGX $54.81
  • TNL $60.08
  • Average True Range (ATR)
  • PTGX 2.11
  • TNL 1.68
  • MACD
  • PTGX -0.52
  • TNL -0.53
  • Stochastic Oscillator
  • PTGX 8.78
  • TNL 33.83

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About TNL Travel Leisure Co. Common Stock

Travel+Leisure Co is a membership and leisure travel company. It provides hospitality services and travel products. The company operates in the segments of Vacation Ownership, which is the key revenue-driving segment, develops, markets and sells vacation ownership interests (VOIs) to individual consumers, provides consumer financing in connection with the sale of VOIs, and provides property management services at resorts, and Travel and Membership which operates a variety of travel businesses, including three vacation exchange brands, a home exchange network, travel technology platforms, travel memberships, and direct-to-consumer rentals. The majority of the revenue is earned from the United States.

Share on Social Networks: